CORELENS S.A. ZY -10 (9GK) - Total Liabilities
Based on the latest financial reports, CORELENS S.A. ZY -10 (9GK) has total liabilities worth €20.84 Million EUR (≈ $24.36 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CORELENS S.A. ZY -10 - Total Liabilities Trend (2021–2025)
This chart illustrates how CORELENS S.A. ZY -10's total liabilities have evolved over time, based on quarterly financial data. See how liquid is CORELENS S.A. ZY -10's working capital to evaluate short-term liquidity relative to the company's equity base.
CORELENS S.A. ZY -10 Competitors by Total Liabilities
The table below lists competitors of CORELENS S.A. ZY -10 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hemogenyx Pharmaceuticals PLC
LSE:HEMO
|
UK | GBX3.65 Million |
|
Staffline Group Plc
LSE:STAF
|
UK | GBX198.60 Million |
|
Storage Drop Storage Technologies Ltd
TA:STRG
|
Israel | ILA3.25 Million |
|
Oxbridge Re Holdings Equity Warrant
NASDAQ:OXBRW
|
USA | $1.56 Million |
|
Works co uk PLC
LSE:WRKS
|
UK | GBX111.11 Million |
|
Glass To Power SpA
PA:MLGLB
|
France | €1.12 Million |
|
Blencowe Resources Plc
LSE:BRES
|
UK | GBX1.50 Million |
|
DCI Advisors Limited
LSE:DCI
|
UK | GBX64.88 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down CORELENS S.A. ZY -10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 9GK stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 64.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.98 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CORELENS S.A. ZY -10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CORELENS S.A. ZY -10 (2021–2025)
The table below shows the annual total liabilities of CORELENS S.A. ZY -10 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €20.84 Million ≈ $24.36 Million |
-22.46% |
| 2024-12-31 | €26.87 Million ≈ $31.42 Million |
+20.62% |
| 2023-12-31 | €22.28 Million ≈ $26.05 Million |
+18.29% |
| 2022-12-31 | €18.83 Million ≈ $22.02 Million |
-13.12% |
| 2021-12-31 | €21.68 Million ≈ $25.35 Million |
-- |
About CORELENS S.A. ZY -10
Zortrax S.A. develops, manufactures, and sells 3D printing solutions for business professionals. It offers 3D printers, post-processing device, filaments, and resins; 3D printing farm management software; and Zortrax inCloud. The company's products are used in aerospace and defense, automotive, rapid prototyping, professional electronics, production line support, packaging design, medicine, jewel… Read more